Priscilla Merriam

8PUBLICATIONS

79CO-AUTHORS

Molecular targetsAnimal systematics and taxonomyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Solid tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jul 06, 2026

Patterns of Response to Immune Checkpoint Inhibitors in Sarcomas With High Tumor Burden and/or Mismatch Repair Deficiency.

|May 26, 2026

Fibroblast growth factor receptor inhibition for succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 2 trial.

|Apr 18, 2026

Atezolizumab for Alveolar Soft Part Sarcoma: A Clinical Trial Update.

|Jan 02, 2026

A Phase 2 Study of Eribulin in Patients with Metastatic Angiosarcoma and Epithelioid Hemangioendothelioma.

Gregory M Cote, Mason Aberoumand, Edwin Choy

|May 09, 2024

Safety and Efficacy of the Combination Lurbinectedin plus Doxorubicin from a Phase 1b Trial in Patients with Advanced/Metastatic Soft-Tissue Sarcoma.

Gregory M Cote, Candace L Haddox, Edwin Choy

|Jan 18, 2024

Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates.

Candace L Haddox, Michael J Nathenson, Emanuele Mazzola

Pageof 2

Frequent Collaborators

Suzanne George

Edwin Choy

Gregory M Cote

Candace L Haddox

Emanuele Mazzola

Andrew J Wagner

Vinayak Venkataraman

Thierry Alcindor

George Demetri

Michael J Nathenson

Frequent Collaborators

Suzanne George

Edwin Choy

Gregory M Cote

Candace L Haddox